林华医疗 (835637.OC)

+ 收藏

现金流量表(林华医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 1,046,523,657.59476,427,244.92914,234,443.41392,498,632.01
 收到的税费返还(元) 9,743,484.89-1,346,927.88732,594.75
 收到其他与经营活动有关的现金(元) 22,957,624.8410,869,413.8120,702,355.9216,040,321.42
 经营活动现金流入小计(元) 1,079,224,767.32487,296,658.73936,283,727.21409,271,548.18
 购买商品、接受劳务支付的现金(元) 198,555,228.8080,393,154.68167,201,913.0964,516,477.39
 支付给职工以及为职工支付的现金(元) 386,553,250.03213,084,028.15342,774,127.93193,834,940.48
 支付的各项税费(元) 145,649,334.8848,509,758.22111,112,892.6061,415,294.65
 支付其他与经营活动有关的现金(元) 76,693,820.9750,465,626.6071,239,736.3731,572,086.71
 经营活动现金流出小计(元) 807,451,634.68392,452,567.65692,328,669.99351,338,799.23
 经营活动产生的现金流量净额(元) 271,773,132.6494,844,091.08243,955,057.2257,932,748.95
二、投资活动产生的现金流量
 收回投资收到的现金(元) 234,000,000.00100,000,000.00859,000,000.00625,000,000.00
 取得投资收益收到的现金(元) 1,314,253.01404,133.754,138,744.421,122,807.12
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 1,321,731.09160,410.12453,434.10448,357.96
 收到其他与投资活动有关的现金(元) -439,196.47--
 投资活动现金流入小计(元) 236,635,984.10101,003,740.34863,592,178.52626,571,165.08
 购建固定资产、无形资产和其他长期资产支付的现金(元) 93,156,154.5345,263,835.71110,363,642.6554,315,756.16
 投资支付的现金(元) 306,000,000.00162,000,000.00762,954,726.03579,000,000.00
 支付其他与投资活动有关的现金(元) ---2,092,071.92
 投资活动现金流出小计(元) 399,156,154.53207,263,835.71873,318,368.68635,407,828.08
 投资活动产生的现金流量净额(元) -162,520,170.43-106,260,095.37-9,726,190.16-8,836,663.00
三、筹资活动产生的现金流量
 收到其他与筹资活动有关的现金(元) --1,500,000.00-
 筹资活动现金流入小计(元) --1,500,000.00-
 分配股利、利润或偿付利息支付的现金(元) 72,072,000.0072,072,000.0072,084,662.1172,072,000.00
 支付其他与筹资活动有关的现金(元) 1,145,242.78-92,351,076.581,540,040.82
 筹资活动现金流出小计(元) 73,217,242.7872,072,000.00164,435,738.6973,612,040.82
 筹资活动产生的现金流量净额(元) -73,217,242.78-72,072,000.00-162,935,738.69-73,612,040.82
四、汇率变动对现金及现金等价物的影响(元) 192,670.41215,646.561,419,935.411,934,226.10
五、现金及现金等价物净增加额(元) 36,228,389.84-83,272,357.7372,713,063.78-22,581,728.77
 加:期初现金及现金等价物余额(元) 268,762,726.28268,762,726.28196,049,662.50195,393,172.49
 期末现金及现金等价物余额(元) 304,991,116.12185,490,368.55268,762,726.28172,811,443.72
补充资料:
 净利润(元) 213,803,378.2988,314,318.31184,245,491.4884,533,224.87
 资产减值准备(元) 943,607.5728,140.491,434,292.1417,838.47
 固定资产和投资性房地产折旧(元) 52,108,138.9023,275,585.2945,313,824.7018,196,396.42
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 52,108,138.9023,275,585.2945,313,824.7018,196,396.42
 无形资产摊销(元) 5,240,260.6822,101,286.905,209,531.92427,026.25
 长期待摊费用摊销(元) 19,971.2819,971.28261,354.34237,388.78
 处置固定资产、无形资产和其他长期资产的损失(元) 88,408.40-109,843.652,629,684.32-107,241.13
 固定资产报废损失(元) 9,047,250.03574,248.93131,312.82123,823.70
 公允价值变动损失(元) -98,065.76-76,931.50182,767.12-148,602.74
 财务费用(元) -44,896.03-413,455.66-2,665,584.20-2,040,168.88
 投资损失(元) -3,308,003.01-1,369,939.77-4,138,744.42-1,982,539.68
 递延所得税(元) 3,233,668.654,758,425.0911,183,245.172,605,821.25
  其中:递延所得税资产减少(元) 6,670,400.496,104,008.058,127,769.542,556,971.94
 递延所得税负债增加(元) -3,436,731.84-1,345,582.963,055,475.6348,849.31
 存货的减少(元) -10,071,168.95-8,816,021.24-20,323,050.55-6,058,108.64
 经营性应收项目的减少(元) 2,874,952.99-2,148,262.393,646,555.80-3,493,147.02
 经营性应付项目的增加(元) -3,387,677.92-33,557,482.8714,039,371.16-36,487,785.55
 现金的期末余额(元) 304,991,116.12185,490,368.55268,762,726.28172,811,443.72
 减:现金的期初余额(元) 268,762,726.28268,762,726.28196,049,662.50195,393,172.49
 现金及现金等价物的净增加额(元) 36,228,389.84-83,272,357.7372,713,063.78-22,581,728.77
公告日期 2024-04-252023-08-242023-04-252022-08-24
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院